Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Br J Haematol. 2015 Oct 12;171(5):788–797. doi: 10.1111/bjh.13773

Fig 2.

Fig 2

Fig 2

Adjusted outcomes for patients with mantle cell lymphoma following autologous stem cell transplantation with or without high-dose radioimmunotherapy-based conditioning. Progression-free (A) and overall survival (B) for all patients included in this analysis, depicted as Kaplan-Meier curves. The Control group acts as a reference while the radioimmunotherapy (RIT) group is adjusted via the important covariates (chemosensitivity, remission status at autologous stem cell transplantation [ASCT], ASCT in first remission, and age). These adjustments incorporate the important covariates along with the hazard ratio estimates. P-values are the results of Cox proportional hazard models. Tick marks represent censored events. Prob, probability.